Health New Approaches in the Bladder-Sparing Paradigm James Pereira Mar 21, 2023 In this exclusive roundtable video… Read More...
Health Precision Oncology for Patients With Metastatic Urothelial Carcinoma James Pereira Jan 1, 2023 Antibody-drug conjugates, a new class of drugs are approved for patients with metastatic urothelial carcinoma.… Read More...
Health Terry Bradshaw’s Merkel Cell Carcinoma James Pereira Nov 11, 2022 With football back in… Read More...
Health Terry Bradshaw says he’s been treated for 2 kinds of cancer James Pereira Oct 3, 2022 FILE - Fox commentator Terry Bradshaw is sen before the NFC Championship NFL football game between the Los Angeles Rams… Read More...
Health Bladder Cancer Immunotherapy Response may be Predicted by Genetics James Pereira Aug 9, 2022 Anti-PD-1/PD-L1 therapy, a type of cancer immunotherapy that opens the door for the body's immune system to attack… Read More...
LifeStyle Bladder cancer immunotherapy response can be predicted by genetics: Researchers Taner Halicioglu Aug 8, 2022 Anti-PD-1/PD-L1 therapy--a type of cancer immunotherapy that paves the way for the body's immune system to attack… Read More...
Health Atezolizumab Improves Survival Rate in Bladder Cancer Patients James Pereira Jul 4, 2022 Results showed no significant difference in overall survival between the two groups in the intention-to-treat… Read More...
Health Theralase® Research – One of the Top 10 Most Downloaded Papers James Pereira Jun 25, 2022 TORONTO, June 24, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT)… Read More...
Health Bladder Cancer: Immunotherapy After Surgery Improves Cancer-Free Survival Rates James Pereira May 15, 2022 About 700 patients participated in phase 3, randomized, double-blind trial named CheckMate 274; half were given… Read More...
Health Mutation-targeted Bladder Cancer Drug Found Under-used James Pereira May 15, 2022 ," said study lead author Vivek Nimgaonkar, a Perelman School of Medicine student and graduate associate with the Penn… Read More...